PROTHENA CORP PUBLIC LTD CO·4

Feb 17, 6:42 PM ET

Harfstrand Karl Anders Olof 4

4 · PROTHENA CORP PUBLIC LTD CO · Filed Feb 17, 2021

Insider Transaction Report

Form 4
Period: 2021-02-12
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2021-02-1230,0000 total
    Exercise: $49.60From: 2018-05-14Exp: 2025-06-29Ordinary Shares (30,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-02-12+15,87315,873 total
    Exercise: $22.85Exp: 2025-06-29Ordinary Shares (15,873 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2021-02-1215,0000 total
    Exercise: $42.50From: 2017-05-16Exp: 2026-05-20Ordinary Shares (15,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-02-12+8,4268,426 total
    Exercise: $22.85Exp: 2026-05-20Ordinary Shares (8,426 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2021-02-1212,0000 total
    Exercise: $56.23From: 2018-05-14Exp: 2027-05-18Ordinary Shares (12,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-02-12+6,3156,315 total
    Exercise: $22.85Exp: 2027-05-18Ordinary Shares (6,315 underlying)
Footnotes (4)
  • [F1]On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on June 29, 2015. In exchange, the reporting person received a replacement option, for 15,873 ordinary shares, having an exercise price of $22.85 per ordinary share.
  • [F2]The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.
  • [F3]On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share.
  • [F4]On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4